The most remarkable advantage of beta blockers as compared to other HF therapies, including the use of ACE inhibitors, angiotensin receptor blockers (ARBs), and diuretics, is that they increase LVEF, thus lowering mortality level. The gene discussed is ACE; the disease is hydrops fetalis.